Simopoulos T, et al. - Researchers conducted a retrospective, single academic center study to determine if any of the factors noted on a standard clinical history of a patient considered for spinal cord stimulation (SCS) would be correlated with decrease or cessation of opioids following implantation. Among 214 patients who met criteria for analysis (median age of 50 years), the majority were having the diagnoses of failed back surgery syndrome and complex regional pain syndrome. Complete cessation of opioid use was identified to be only associated with a median dose of 30 mg of morphine per day, which was observed in 15% of individuals who used opioids preoperatively. Outcomes suggest that the daily dose highly influence the elimination of opioid dependence following initiation of SCS therapy.